SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-14-000037
Filing Date
2014-08-08
Accepted
2014-08-07 18:48:24
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 995752
2 exhibit12.htm EX-12 59547
3 exhibit31_1.htm EX-31.1 13866
4 exhibit31_2.htm EX-31.2 13848
5 exhibit32_1.htm EX-32.1 3325
6 exhibit32_2.htm EX-32.2 3277
  Complete submission text file 0001367644-14-000037.txt   6333218

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ebs-20140630.xml EX-101.INS 932097
8 XBRL TAXONOMY EXTENSION SCHEMA ebs-20140630.xsd EX-101.SCH 33349
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20140630_cal.xml EX-101.CAL 71736
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20140630_def.xml EX-101.DEF 158809
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20140630_lab.xml EX-101.LAB 543724
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20140630_pre.xml EX-101.PRE 303039
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 141025222
SIC: 2834 Pharmaceutical Preparations